Back to Search Start Over

Pyridoxal kinase: A vitamin B6 salvage pathway enzyme from Leishmania donovani.

Authors :
Kumar, Vinay
Sharma, Mahesh
Rakesh, Bhadoriya Ruchita
Malik, Chandan Kumar
Neelagiri, Soumya
Neerupudi, Kishore Babu
Garg, Prabha
Singh, Sushma
Source :
International Journal of Biological Macromolecules. Nov2018, Vol. 119, p320-334. 15p.
Publication Year :
2018

Abstract

Abstract Pyridoxal kinase (PdxK, EC 2.7.1.35) is an important enzyme of vitamin B6 salvage pathway which is required for phosphorylation of B6 vitamers. In the present study, pyridoxal kinase (pdxK) gene from Leishmania donovani (Ld PdxK) was cloned and a 33 kDa protein was expressed and kinetically characterized. Site-directed mutagenesis was performed to determine the functional significance of conserved GXGD motif. Mutation of Thr229 to Ala did not affect the catalytic function of Ld PdxK however Gly228, Gly230 and Asp231 were found to be indispensible for enzyme activity. To determine the role of Ld PdxK in Leishmania promastigotes, Ld PdxK overexpressing parasites were generated by episomal expression of the enzyme. The overexpression studies revealed the role of this enzyme in growth and infection of the parasite. In silico analysis of the human and parasite PdxK structure revealed significant differences in the active site region thus highlighting its potential as an antileishmanial drug target. Homology model of Ld PdxK was built and was subjected to molecular dynamics simulations. Based on the above information, a pharmacophore was developed and shape based virtual screening was performed to identify potential and selective inhibitors against this essential enzyme. The current data suggests that Ld PdxK could be a promising antileishmanial drug target. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01418130
Volume :
119
Database :
Academic Search Index
Journal :
International Journal of Biological Macromolecules
Publication Type :
Academic Journal
Accession number :
131732589
Full Text :
https://doi.org/10.1016/j.ijbiomac.2018.07.095